New pill aims to tackle high blood pressure and weight together
Disease control
Not yet recruiting
This study tests a new drug called VCT220 in 160 adults with high blood pressure who are also overweight or obese. Participants will take either VCT220 or a placebo pill for 20 weeks. The main goal is to see if VCT220 can safely lower blood pressure more than a placebo.
Phase: PHASE2 • Sponsor: Vincentage Pharma Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC